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Identity 
Other names: SEB 
HGNC (Hugo): SETBP1 
Location: 18q12.3 
Local order: From centromere to telomere: SETBP1, 
SMAD2, SMAD4, BCL2. 
DNA/RNA 
Description 
SETBP1 has two isoforms: transcript variant a spans 
387,61 kb on the genomic DNA and has 6 exons; 
transcript variant b spans 197,24 kb on the genomic 
DNA and includes 4 exons. 
Transcription 




Two isoforms: variant a (1596 amino acids); variant b 
(242 amino acids). 
Expression 
Expressed in numerous tissues. 
Localisation 
Predominantly in the nucleus (Minakuchi et al., 2001; 
Cristóbal et al., 2010). 
Function 
SETBP1 overexpression promotes leukemogenesis by 
enhancing full-length SET protein and then impairing 
the phosphatase activity of the tumor suppressor PP2A 
in acute myeloid leukaemia. In addition, defects in 
SETBP1 have been described as the cause of Schinzel-
Giedion syndrome. 
Homology 
The protein contains a region homologous to the 
dimerization domain of the SKI oncoprotein, six PEST 
sequences, three AT-hook DNA binding domains, a 




De novo mutations have been decribed in patients with 
Schinzel-Giedion syndrome: I871T (5 unrelated 
patients), D868N (4 unrelated patients), D868A (one 
case), G870D (one case) and G870S (three unrelated 
patients) (Hoischen et al., 2010; Suphapeetiporn et al., 
2011). 
Implicated in 
Pediatric T-cell acute lymphoblastic 
leukemia (T-ALL) (Panagopoulos et al., 
2007) 
Cytogenetics 
t(11;18)(p15;q12); only one case decribed so far. 
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Hybrid/Mutated gene 
5' NUP98 - 3' SETBP1 
Abnormal protein 
The NUP98-SETBP1 fusion protein consists in the 
exon 12 of NUP98 fused in-frame with exon 5 of 
SETBP1. 
Oncogenesis 
SETBP1/NUP98 expression was not detected, 




Defects in SETBP1 caused by the presence of the novo
mutations have been described as the cause of 
Schinzel-Giedion midface retraction syndrome. 
Cytogenetics 
Normal karyotype. 
Acute myeloid leukemia (AML) 
Prognosis 
SETBP1 overexpression associates with worse overall 
survival specially in the subgroup of elderly patien s 




The presence of a t(12;18)(p13;q12) has been describ  
in one case with AML secondary to myelodysplastic 
syndrome (figure 1) (Cristóbal et al., 2010), and i one 
case with AML secondary to primary myelofibrosis 
(Albano et al., 2012). 
Oncogenesis 
SETBP1 overexpression promotes leukemogenesis by 
enhancing full-length SET protein and then impairing 
the phosphatase activity of the tumor suppressor PP2A 
through the formation of a SETBP1-SET-PP2A 
complex. 
References 
Minakuchi M, Kakazu N, Gorrin-Rivas MJ, Abe T, Copeland 
TD, Ueda K, Adachi Y. Identification and characterization of 
SEB, a novel protein that binds to the acute undifferentiated 
leukemia-associated protein SET. Eur J Biochem. 2001 
Mar;268(5):1340-51 
Panagopoulos I, Kerndrup G, Carlsen N, Strömbeck B, 
Isaksson M, Johansson B. Fusion of NUP98 and the SET 
binding protein 1 (SETBP1) gene in a paediatric acute T cell 
lymphoblastic leukaemia with t(11;18)(p15;q12). Br J 
Haematol. 2007 Jan;136(2):294-6 
Cristóbal I, Blanco FJ, Garcia-Orti L, Marcotegui N, Vicente C, 
Rifon J, Novo FJ, Bandres E, Calasanz MJ, Bernabeu C, 
Odero MD. SETBP1 overexpression is a novel leukemogenic 
mechanism that predicts adverse outcome in elderly patients 
with acute myeloid leukemia. Blood. 2010 Jan 21;115(3):615-
25 
Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, 
Steehouwer M, de Vries P, de Reuver R, Wieskamp N, Mortier 
G, Devriendt K, Amorim MZ, Revencu N, Kidd A, Barbosa M, 
Turner A, Smith J, Oley C, Henderson A, Hayes IM, Thompson 
EM, Brunner HG, de Vries BB, Veltman JA. De novo mutations 
of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet. 
2010 Jun;42(6):483-5 
Suphapeetiporn K, Srichomthong C, Shotelersuk V. SETBP1 
mutations in two Thai patients with Schinzel-Giedion 
syndrome. Clin Genet. 2011 Apr;79(4):391-3 
Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Minervini 
A, Specchia G. SETBP1 and miR_4319 dysregulation in 
primary myelofibrosis progression to acute myeloid leukemia. J 
Hematol Oncol. 2012 Aug 8;5:48 
This article should be referenced as such: 
Cristóbal I, García-Orti L, Odero MD. SETBP1 (SET binding 
protein 1). Atlas Genet Cytogenet Oncol Haematol. 2013; 
17(3):159-160. 
